AVE Science & Technology Co

AVE Science & Technology Co Capital Expenditures

The Capital Expenditures (CapEx) of AVE Science & Technology Co (688067.SS) as of Oct 19, 2026 is -3.21 M CNY. In the previous year, Capital Expenditures (CapEx) was -3.75 M CNY — a change of -14.39% (higher).

Capital Expenditures

-3.21 MCNY

YoY

-14.39%

Last updated:

Capital Expenditures (CapEx) of AVE Science & Technology Co is 2025 -3.21 M CNY. Capital Expenditures (CapEx) of AVE Science & Technology Co was 2024 -3.75 M CNY. It decreases by -14.39% higher compared to the previous year.

The AVE Science & Technology Co Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2018
-17.37 M CNY
Jan 1, 2019
-24.49 M CNY
Jan 1, 2020
-11.80 M CNY
Jan 1, 2021
-20.52 M CNY
Jan 1, 2022
-21.20 M CNY
Jan 1, 2023
-4.50 M CNY
Jan 1, 2024
-3.75 M CNY
Jan 1, 2025
-3.21 M CNY
The AVE Science & Technology Co Capital Expenditures history
YEARCapital ExpendituresYoY
-3.21 MCNY-14.39%
-3.75 MCNY-16.61%
-4.50 MCNY-78.79%
-21.20 MCNY+3.36%
-20.52 MCNY+73.80%
-11.80 MCNY-51.80%
-24.49 MCNY+40.97%
-17.37 MCNY-63.86%
-48.06 MCNY+113.95%
-22.46 MCNY+26.07%
-17.82 MCNY-53.98%
-38.72 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

AVE Science & Technology Co Stock analysis

What does AVE Science & Technology Co do? AVE Science & Technology Co Ltd, based in Changsha, China, operates in the Health Care sector, specializing in clinical testing and analysis instruments. The company develops, produces, and sells a range of diagnostic equipment, including urine and stool analyzers, body fluid analyzers, and reproductive tract secretion analyzers, alongside related reagents and consumables. With 545 employees, it serves domestic and international markets, focusing on medical and health institutions for diagnostic solutions. AVE Science & Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AVE Science & Technology Co stock

Capital Expenditures (CapEx) of AVE Science & Technology Co is -3.21 M CNY in 2025.

Capital Expenditures (CapEx) of AVE Science & Technology Co changed from -3.75 M CNY to -3.21 M CNY, representing a -14.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) AVE Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s AVE Science & Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — AVE Science & Technology Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — AVE Science & Technology Co